Povorcitinib 75 mg achieved high-threshold lesion clearance by week 12, including 100% draining-tunnel reduction in 12%–57% and total abscess clearance in 22%–62% of participants. Phase 3 data show ...

The partnership connects structured clinical data with EHR workflows to accelerate referrals, care coordination, and ...

Zygomatic implants represent one of the most significant advances in treatment options for seniors with severe maxillary bone ...

“Our partnership with CRIO accelerates our strategy connecting site-level eSource and the Medidata Platform,” said Tom Doyle, chief technology officer, Medidata. “This will accelerate workflows for ...

NEEDHAM, MA, UNITED STATES, February 10, 2026 /EINPresswire.com/ -- Trialt, a global clinical research organization ...

A research team has developed a versatile machine learning model that could one day greatly expand what medical scans can tell us about disease. Scientists used their tool, named Merlin, to assess 3D ...

Kensington, MD, USA and Munich/Martinsried, Germany, March 05, 2026 (GLOBE NEWSWIRE) -- Galimedix Therapeutics to present promising pre-clinical data with next generation oral amyloid beta aggregation ...

As a CMS-approved QCDR, OneOncology is authorized to collect clinical data from a variety of sources and report MIPS measures for partner practices and their clinicians across all of their EMR ...

Prof. Dr. Guido van Wingen discusses the potential of, and barriers to, the use of AI in transforming the treatment of depression ...

JOURNAVX met the primary endpoint by demonstrating statistically significant superior reduction in pain vs placebo. 1,b JOURNAVX did not meet the first key secondary endpoint that hypothesized ...

For sura-vec in wet AMD, top line data from pivotal studies ATMOSPHERE and ASCENT are anticipated in Q4. First patient dosing in NAVIGATE for diabetic retinopathy is planned next quarter, expected to ...

This article is part of our series on clinical data considerations. Read How to Prepare for Disclosure. For publicly traded biotech companies, disclosing clinical trial data can be an exciting ...